BPT_VIBVU
ID BPT_VIBVU Reviewed; 232 AA.
AC Q8DAR7;
DT 25-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT 12-JUN-2007, sequence version 2.
DT 03-AUG-2022, entry version 111.
DE RecName: Full=Aspartate/glutamate leucyltransferase {ECO:0000255|HAMAP-Rule:MF_00689, ECO:0000305};
DE EC=2.3.2.29 {ECO:0000255|HAMAP-Rule:MF_00689, ECO:0000269|PubMed:16492767};
DE AltName: Full=Bacterial protein transferase {ECO:0000303|PubMed:16492767};
GN Name=bpt {ECO:0000255|HAMAP-Rule:MF_00689, ECO:0000303|PubMed:16492767};
GN OrderedLocusNames=VV1_2124;
OS Vibrio vulnificus (strain CMCP6).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Vibrionales; Vibrionaceae;
OC Vibrio.
OX NCBI_TaxID=216895;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=CMCP6;
RA Rhee J.H., Kim S.Y., Chung S.S., Kim J.J., Moon Y.H., Jeong H., Choy H.E.;
RT "Complete genome sequence of Vibrio vulnificus CMCP6.";
RL Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN [2]
RP SEQUENCE REVISION.
RA Rhee J.H., Kim S.Y., Chung S.S., Lee S.E., Choy H.E.;
RL Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN [3]
RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF CYS-18; TYR-58; TYR-170
RP AND TYR-205.
RX PubMed=16492767; DOI=10.1073/pnas.0511224103;
RA Graciet E., Hu R.G., Piatkov K., Rhee J.H., Schwarz E.M., Varshavsky A.;
RT "Aminoacyl-transferases and the N-end rule pathway of
RT prokaryotic/eukaryotic specificity in a human pathogen.";
RL Proc. Natl. Acad. Sci. U.S.A. 103:3078-3083(2006).
CC -!- FUNCTION: Functions in the N-end rule pathway of protein degradation
CC where it conjugates Leu from its aminoacyl-tRNA to the N-termini of
CC proteins containing an N-terminal aspartate or glutamate.
CC {ECO:0000255|HAMAP-Rule:MF_00689, ECO:0000269|PubMed:16492767}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-leucyl-tRNA(Leu) + N-terminal L-glutamyl-[protein] = H(+) +
CC N-terminal L-leucyl-L-glutamyl-[protein] + tRNA(Leu);
CC Xref=Rhea:RHEA:50412, Rhea:RHEA-COMP:9613, Rhea:RHEA-COMP:9622,
CC Rhea:RHEA-COMP:12664, Rhea:RHEA-COMP:12668, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:64721, ChEBI:CHEBI:78442, ChEBI:CHEBI:78494,
CC ChEBI:CHEBI:133041; EC=2.3.2.29; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_00689, ECO:0000269|PubMed:16492767};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-leucyl-tRNA(Leu) + N-terminal L-aspartyl-[protein] = H(+) +
CC N-terminal L-leucyl-L-aspartyl-[protein] + tRNA(Leu);
CC Xref=Rhea:RHEA:50420, Rhea:RHEA-COMP:9613, Rhea:RHEA-COMP:9622,
CC Rhea:RHEA-COMP:12669, Rhea:RHEA-COMP:12674, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:64720, ChEBI:CHEBI:78442, ChEBI:CHEBI:78494,
CC ChEBI:CHEBI:133042; EC=2.3.2.29; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_00689, ECO:0000269|PubMed:16492767};
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00689,
CC ECO:0000305}.
CC -!- SIMILARITY: Belongs to the R-transferase family. Bpt subfamily.
CC {ECO:0000255|HAMAP-Rule:MF_00689, ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE016795; AAO10511.2; -; Genomic_DNA.
DR RefSeq; WP_011080005.1; NC_004459.3.
DR AlphaFoldDB; Q8DAR7; -.
DR SMR; Q8DAR7; -.
DR EnsemblBacteria; AAO10511; AAO10511; VV1_2124.
DR KEGG; vvu:VV1_2124; -.
DR HOGENOM; CLU_077607_0_0_6; -.
DR OMA; MVEDSHV; -.
DR BioCyc; MetaCyc:MON-19912; -.
DR Proteomes; UP000002275; Chromosome 1.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0004057; F:arginyltransferase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0008914; F:leucyltransferase activity; IEA:InterPro.
DR GO; GO:0071596; P:ubiquitin-dependent protein catabolic process via the N-end rule pathway; IEA:InterPro.
DR HAMAP; MF_00689; Bpt; 1.
DR InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR InterPro; IPR017138; Asp_Glu_LeuTrfase.
DR InterPro; IPR030700; N-end_Aminoacyl_Trfase.
DR InterPro; IPR007472; N-end_Aminoacyl_Trfase_C.
DR InterPro; IPR007471; N-end_Aminoacyl_Trfase_N.
DR PANTHER; PTHR21367; PTHR21367; 2.
DR Pfam; PF04377; ATE_C; 1.
DR Pfam; PF04376; ATE_N; 1.
DR PIRSF; PIRSF037208; ATE_pro_prd; 1.
DR SUPFAM; SSF55729; SSF55729; 1.
PE 1: Evidence at protein level;
KW Acyltransferase; Cytoplasm; Transferase.
FT CHAIN 1..232
FT /note="Aspartate/glutamate leucyltransferase"
FT /id="PRO_0000207256"
FT MUTAGEN 18
FT /note="C->S: Loss of activity."
FT /evidence="ECO:0000269|PubMed:16492767"
FT MUTAGEN 58
FT /note="Y->F: Strong decrease in activity."
FT /evidence="ECO:0000269|PubMed:16492767"
FT MUTAGEN 170
FT /note="Y->F: Almost loss of activity."
FT /evidence="ECO:0000269|PubMed:16492767"
FT MUTAGEN 205
FT /note="Y->F: Almost loss of activity."
FT /evidence="ECO:0000269|PubMed:16492767"
SQ SEQUENCE 232 AA; 27378 MW; C60EA1E9550116D3 CRC64;
MSSDIHQIKI GLTDNHPCSY LPERKERVAV ALEADMHTAD NYEVLLANGF RRSGNTIYKP
HCDSCHSCQP IRISVPDIEL SRSQKRLLAK ARSLSWSMKR NMDENWFDLY SRYIVARHRN
GTMYPPKKDD FAHFSRNQWL TTQFLHIYEG QRLIAVAVTD IMDHCASAFY TFFEPEHELS
LGTLAVLFQL EFCQEEKKQW LYLGYQIDEC PAMNYKVRFH RHQKLVNQRW QG